Jianzhong B. Cao

Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 99 publications

Reshaping immunotherapy sequencing strategy: equivalent survival with induction plus consolidation vs. consolidation-only strategy in unresectable stage III NSCLC.

Reshaping immunotherapy sequencing strategy: equivalent survival with induction plus consolidation vs. consolidation-only strategy in unresectable stage III NSCLC.

Journal: Oncoimmunology

Published: May 16, 2026

The NRF2 signaling pathway in hepatocellular carcinoma: dual roles, epigenetic reprogramming, and therapeutic opportunities in metabolic vulnerability.

The NRF2 signaling pathway in hepatocellular carcinoma: dual roles, epigenetic reprogramming, and therapeutic opportunities in metabolic vulnerability.

Journal: Frontiers in oncology

Published: May 07, 2026

Dynamic Evolution of Fe3O4 Nanoparticles' Protein Corona during Extracellular to Intracellular Trafficking: The Interference of Integrin αMβ2.

Dynamic Evolution of Fe3O4 Nanoparticles' Protein Corona during Extracellular to Intracellular Trafficking: The Interference of Integrin αMβ2.

Journal: Environmental science & technology

Published: April 13, 2026

Co-Cu bimetallic MOF-derived nanozyme-based colorimetric immunoassay with smartphone-based RGB readout for sensitive detection of alpha-fetoprotein.

Co-Cu bimetallic MOF-derived nanozyme-based colorimetric immunoassay with smartphone-based RGB readout for sensitive detection of alpha-fetoprotein.

Journal: Analytical methods : advancing methods and applications

Published: April 10, 2026

A real-world multicenter study on postoperative adjuvant treatment patterns and prognostic implications following neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma.

A real-world multicenter study on postoperative adjuvant treatment patterns and prognostic implications following neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma.

Journal: Frontiers in immunology

Published: February 15, 2026

Clinical efficacy and safety of an overall strategy of immunotherapy combined with chemoradiotherapy for limited-stage small cell lung cancer (including induction ± consolidation ± second-line immunotherapy): A propensity score matching study based on real-world data.

Clinical efficacy and safety of an overall strategy of immunotherapy combined with chemoradiotherapy for limited-stage small cell lung cancer (including induction ± consolidation ± second-line immunotherapy): A propensity score matching study based on real-world data.

Journal: Cancer treatment and research communications

Published: November 10, 2025

In Reply to Noguchi et al.

In Reply to Noguchi et al.

Journal: International journal of radiation oncology, biology, physics

Published: November 04, 2025

Risk stratification model based on estimated dose of radiation to immune cells and radiotherapy-related nadir lymphocyte count for predicting the efficacy of consolidation immunotherapy in stage III non-small cell lung cancer.

Risk stratification model based on estimated dose of radiation to immune cells and radiotherapy-related nadir lymphocyte count for predicting the efficacy of consolidation immunotherapy in stage III non-small cell lung cancer.

Journal: Frontiers in immunology

Published: October 28, 2025

Exploratory analysis of prognostic factors and hematologic dynamics in unresectable ESCC treated with concurrent versus interval immune checkpoint inhibitors combined with (chemo)radiotherapy: a multicenter real-world study.

Exploratory analysis of prognostic factors and hematologic dynamics in unresectable ESCC treated with concurrent versus interval immune checkpoint inhibitors combined with (chemo)radiotherapy: a multicenter real-world study.

Journal: Frontiers in immunology

Published: October 20, 2025

Radiotherapy dose may not affect prognosis in ESCC patients receiving first-line chemoradiotherapy-immunotherapy: A multicenter retrospective study.

Radiotherapy dose may not affect prognosis in ESCC patients receiving first-line chemoradiotherapy-immunotherapy: A multicenter retrospective study.

Journal: Cancer immunology, immunotherapy : CII

Published: September 18, 2025

Recent trends in lipid metabolism research in liver cancer: a bibliometric analysis.

Recent trends in lipid metabolism research in liver cancer: a bibliometric analysis.

Journal: Frontiers in oncology

Published: September 12, 2025

Microbiota-mediated modulation of radiosensitivity: mechanisms and therapeutic prospects of oral and gut microbiota, metabolites, and probiotics.

Microbiota-mediated modulation of radiosensitivity: mechanisms and therapeutic prospects of oral and gut microbiota, metabolites, and probiotics.

Journal: Frontiers in microbiology

Published: August 21, 2025

Showing 1-12 of 99

Last Updated: 09/26/2026